Scott Moomaw
Corporate Officer/Principal chez LIQUIDIA CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Scott Moomaw was the founder of RareGen LLC, a company founded in 2018, where he held the title of Chief Operating Officer from 2018 to 2020.
He is currently working at Liquidia Corp.
as the Chief Commercial Officer since 2020.
In his former positions, Mr. Moomaw worked at United Therapeutics Corp.
from 2011 to 2016 as the Associate Vice President-Marketing, and at OPKO Health, Inc. from 2016 to 2018 as the Vice President-Marketing.
Mr. Moomaw completed his undergraduate degree at Miami University and holds an MBA from the University of Michigan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0,20% | 12/04/2024 | 151 881 ( 0,20% ) | 2 M $ | 31/03/2024 |
Postes actifs de Scott Moomaw
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Corporate Officer/Principal | 18/11/2020 |
Anciens postes connus de Scott Moomaw
| Sociétés | Poste | Fin |
|---|---|---|
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Founder | 01/11/2020 |
| OPKO HEALTH, INC. | Sales & Marketing | 01/08/2018 |
| UNITED THERAPEUTICS CORPORATION | Sales & Marketing | 01/05/2016 |
Formation de Scott Moomaw
| Miami University | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| LIQUIDIA CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Commercial Services |
